GlaxoSmithKline 4Q Revenues: $11.0 billion (-3%) 4Q Earnings: $3.7 billion (+5%) FY Revenues: $42.7 billion (-3%) FY Earnings: $13.5 billion (-3%) Comments: Pharmaceutical sales were $7.6 billion in the quarter, down 1% and $29.1 billion for the year, down 2%. Vaccine sales were $1.4 billion in the quarter, up 10%, and $5.4 billion for the year, down 2%. Consumer Healthcare sales were flat at $2.0 billion in the quarter and $8.3 billion for the year. U.S. sales were $3.5 billion in the quar...